Arkolith/Insider Trading/NKTR/Form 4

Robin Howard W

President & CEO, DirectorNEKTAR THERAPEUTICS (NKTR) · full profile →Form 4 · filed Jun 18, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.2M
Net Open-Market Flow
-$1.2M
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 17, 2026Sell(S)6K$60.81$334K60K
Jun 17, 2026Sell(S)5K$61.65$277K55K
Jun 16, 2026Sell(S)5K$59.97$318K70K
Jun 16, 2026Sell(S)5K$60.71$285K65K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-276236) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML